Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 1.125
+0.045 (4.17%)
Aug 27, 2026, 4:08 PM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 460.78 million as of August 27, 2026. Its market cap has decreased by -72.17% in one year.
Market Cap
460.78M
Enterprise Value
585.55M
Revenue
8.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
ChartMarket Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 460.78M, a decrease of -83.27%. That is a compound annual growth rate of -33.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 460.78M | -51.69% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 866.63M |
| 3D Medicines | 773.42M |
| JW (Cayman) Therapeutics Co. | 748.88M |
| Brii Biosciences | 729.03M |
| B&K Corporation | 697.12M |
| Cutia Therapeutics | 679.50M |
| Wuhan YZY Biopharma | 639.70M |
| Shanghai Bio-heart Biological Technology | 507.52M |